Germany· DE-A57-9fd223f4f45f50d4
Erwinase
A crisantaspase product containing crisantaspase, registered in Germany by Porton Biopharma Limited. The same ATC class is registered in 3 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Crisantaspase is registered in 3 of 19 countries.
Countries holding a registration under ATC Crisantaspase (crisantaspase), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 1 of them publish a price we can compare per daily dose
Crisantaspase · ATC Crisantaspase
3 / 19 countries
- Franceprice
- Germany
- United Kingdom
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Crisantaspase
- Manufacturer
- Porton Biopharma Limited
- Country
- Germany (DE)
- ATC code
- Crisantaspase
- ATC class
- Crisantaspase
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Crisantaspase in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEnrylaze 10 mg/0.5 mlJazz Pharmaceuticals Ireland
- SpainENRYLAZE 10 MG/0,5 ML, SOLUCION INYECTABLE Y PARA PERFUSIONJazz Pharmaceuticals Ireland Limited
- FranceENRYLAZE 10 mg/0,5 mL, solution injectable/pour perfusionJAZZ PHARMACEUTICALS IRELAND LIMITED (IRLANDE)
- IrelandEnrylaze 10 mg/0.5 mL solution for injection/infusion.Jazz Pharmaceuticals Ireland Limited
- NetherlandsEnrylaze 10 mg/0,5 ml oplossing voor injectie/infusieJazz Pharmaceuticals Ireland Ltd.
- NorwayErwinasePorton Biopharma Limided
- PolandEnrylazeJazz Pharmaceuticals Ireland Ltd
- IcelandEnrylazeJazz Pharmaceuticals Ireland Ltd
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Erwinase
- Denmark · Erwinase
- Spain · Erwinase
- Finland · Erwinase
- France · Erwinase
- United Kingdom (Northern Ireland) · Erwinase
- Ireland · Erwinase
- Netherlands · Erwinase
- Norway · Erwinase
- Portugal · Erwinase
- Sweden · Erwinase
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb957181-046c-4f69-b36d-670b522c5e48 GET /v1/drugs/eb957181-046c-4f69-b36d-670b522c5e48?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use ,Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Crisantaspase",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about crisantaspase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.